EU recommends Meridia be suspended

European regulatory authorities said an Abbott Laboratories (ABT) diet pill should be suspended from the market because the risks of stroke and heart attack are too great with the medicine. The European Medicines Agency said sibutramine weight-loss products should be suspended from the market in the European Union after a study of 10,000 patients suggested it put them at a higher risk for heart disease. These medicines are sold in Europe under the brand-names Reductil, Reduxade, Zelium and other names; and as Meridia in the U.S. The agency said "the risks of these medicines are greater than their benefits." Abbott sells Meridia in the U.S. and Reductil, Sibutral, Raductil and Ectiva outside the U.S

Bonnie - considering the benefits are minimal at best from what I've seen, the EU was being nice in their statement.